EP4728075A2 - Zusammensetzungen und verfahren zur apoe-modulierung - Google Patents
Zusammensetzungen und verfahren zur apoe-modulierungInfo
- Publication number
- EP4728075A2 EP4728075A2 EP24824221.6A EP24824221A EP4728075A2 EP 4728075 A2 EP4728075 A2 EP 4728075A2 EP 24824221 A EP24824221 A EP 24824221A EP 4728075 A2 EP4728075 A2 EP 4728075A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- nucleic acid
- isolated nucleic
- apoe
- seq
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/322—2'-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/34—Spatial arrangement of the modifications
- C12N2310/341—Gapmers, i.e. of the type ===---===
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363508831P | 2023-06-16 | 2023-06-16 | |
| US202363588136P | 2023-10-05 | 2023-10-05 | |
| US202463556391P | 2024-02-21 | 2024-02-21 | |
| PCT/US2024/034006 WO2024259232A2 (en) | 2023-06-16 | 2024-06-14 | Compositions and methods for modulating apoe |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP4728075A2 true EP4728075A2 (de) | 2026-04-22 |
Family
ID=93852762
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP24824221.6A Pending EP4728075A2 (de) | 2023-06-16 | 2024-06-14 | Zusammensetzungen und verfahren zur apoe-modulierung |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP4728075A2 (de) |
| WO (1) | WO2024259232A2 (de) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021178374A2 (en) * | 2020-03-05 | 2021-09-10 | Synerk Inc. | Compounds and methods for reducing apoe expression |
-
2024
- 2024-06-14 WO PCT/US2024/034006 patent/WO2024259232A2/en not_active Ceased
- 2024-06-14 EP EP24824221.6A patent/EP4728075A2/de active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024259232A3 (en) | 2025-04-17 |
| WO2024259232A2 (en) | 2024-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7354342B2 (ja) | タウ発現を調節するための組成物 | |
| JP6924242B2 (ja) | C9orf72発現を調節するための組成物 | |
| US20220411796A1 (en) | Compositions and methods for decreasing tau expression | |
| US11781135B2 (en) | Methods for treating Alzheimer's disease | |
| EP3449926B1 (de) | Zusammensetzungen und verfahren zur modulation der smn2-aufspaltung im körper eines patienten | |
| EP3061824B1 (de) | Organische zusammensetzungen zur behandlung von beta-enac-bedingten erkrankungen | |
| CN105637090A (zh) | 用于调节c9orf72表达的组合物 | |
| JP2024504266A (ja) | リジン分解関連障害の治療 | |
| EP4728075A2 (de) | Zusammensetzungen und verfahren zur apoe-modulierung | |
| EP4677088A2 (de) | Zusammensetzungen und verfahren zur gls1-modulierung | |
| WO2024187106A2 (en) | Compositions and methods for modulating grin2a | |
| WO2024187102A2 (en) | Compositions and methods for modulating c3 | |
| AU2024231822A1 (en) | Compositions and methods for modulating sptlc1 | |
| HK40108162A (en) | Compositions and methods for decreasing tau expression | |
| WO2024251725A1 (en) | Oligonucleotides targeting gal3st1 | |
| JP2023554579A (ja) | 核内受容体サブファミリー1グループhメンバー3(nr1h3)発現を阻害するための組成物および方法 | |
| HK40000192A (en) | Compositions and methods for modulation of smn2 splicing in a subject | |
| HK40000192B (en) | Compositions and methods for modulation of smn2 splicing in a subject | |
| HK1254822B (en) | Compositions and methods for decreasing tau expression | |
| BR112018012304B1 (pt) | Oligonucleotídeo, seu uso para o tratamento de uma doença associada à tau, e composição |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20251222 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR |